CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+6.21%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$907M
AUM Growth
+$907M
(+28%)
Cap. Flow
+$198M
Cap. Flow
% of AUM
21.86%
Top 10 Holdings %
Top 10 Hldgs %
37.32%
Holding
435
New
22
Increased
337
Reduced
40
Closed
7
Top Buys
| 1 |
Apple
AAPL
|
$25.8M |
| 2 |
Microsoft
MSFT
|
$10.9M |
| 3 |
Amgen
AMGN
|
$7.28M |
| 4 |
NVIDIA
NVDA
|
$6.87M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$6.77M |
Top Sells
| 1 |
Micron Technology
MU
|
$6.44M |
| 2 |
ServiceNow
NOW
|
$5.1M |
| 3 |
Salesforce
CRM
|
$5M |
| 4 |
CrowdStrike
CRWD
|
$4.33M |
| 5 |
Qualcomm
QCOM
|
$3.38M |
Sector Composition
| 1 | Technology | 37.6% |
| 2 | Healthcare | 28.11% |
| 3 | Consumer Discretionary | 12.57% |
| 4 | Communication Services | 9.53% |
| 5 | Consumer Staples | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Biomea Fusion
BMEA
$114M
| $70.3K | 0.01% |
6,964
+2,741
| +65% | +$27.7K |
|
377
Nautilus Biotechnolgy
NAUT
$80.7M
| $68.7K | 0.01% |
24,121
+9,404
| +64% | +$26.8K |
|
378
Lyell Immunopharma
LYEL
$220M
| $67.9K | 0.01% |
49,238
+19,287
| +64% | +$26.6K |
|
379
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.7B
| $63.6K | 0.01% |
+150
| New | +$63.6K |
|
380
MeiraGTx Holdings
MGTX
$590M
| $62.1K | 0.01% |
14,886
+7,330
| +97% | +$30.6K |
|
381
Voyager Therapeutics
VYGR
$204M
| $61.4K | 0.01% |
10,489
+4,098
| +64% | +$24K |
|
382
Atea Pharmaceuticals
AVIR
$275M
| $54.4K | 0.01% |
16,237
+6,343
| +64% | +$21.2K |
|
383
Editas Medicine
EDIT
$225M
| $54.1K | 0.01% |
15,863
+6,202
| +64% | +$21.1K |
|
384
Vanda Pharmaceuticals
VNDA
$279M
| $52.6K | 0.01% |
11,211
+4,374
| +64% | +$20.5K |
|
385
Precigen
PGEN
$1.42B
| $52.4K | 0.01% |
55,337
+25,681
| +87% | +$24.3K |
|
386
Zentalis Pharmaceuticals
ZNTL
$123M
| $50.3K | 0.01% |
13,676
+5,333
| +64% | +$19.6K |
|
387
uniQure
QURE
$954M
| $49.8K | 0.01% |
10,093
+3,663
| +57% | +$18.1K |
|
388
Wolfspeed
WOLF
$203M
| $48.5K | 0.01% |
5,000
-23,000
| -82% | -$223K |
|
|
AMRN
389
Amarin Corp
AMRN
$311M
| $48.2K | 0.01% |
76,959
+29,992
| +64% | +$18.8K |
|
|
EXAI
390
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $46.7K | 0.01% |
9,576
+3,821
| +66% | +$18.6K |
|
391
Cabaletta Bio
CABA
$144M
| $44.3K | ﹤0.01% |
9,395
+3,724
| +66% | +$17.6K |
|
392
Texas Roadhouse
TXRH
$11.4B
| $43.1K | ﹤0.01% |
244
| – | – |
|
393
Fulcrum Therapeutics
FULC
$353M
| $42.8K | ﹤0.01% |
12,002
+4,701
| +64% | +$16.8K |
|
394
Amylyx Pharmaceuticals
AMLX
$877M
| $42.4K | ﹤0.01% |
13,094
+5,104
| +64% | +$16.5K |
|
395
MacroGenics
MGNX
$121M
| $39.7K | ﹤0.01% |
12,064
+4,707
| +64% | +$15.5K |
|
396
ATAI Life Sciences
ATAI
$969M
| $37.4K | ﹤0.01% |
32,273
+12,607
| +64% | +$14.6K |
|
397
Hyatt Hotels
H
$13.7B
| $36.5K | ﹤0.01% |
240
| – | – |
|
398
Caribou Biosciences
CRBU
$176M
| $34.1K | ﹤0.01% |
17,380
+6,768
| +64% | +$13.3K |
|
399
Align Technology
ALGN
$9.59B
| $33.8K | ﹤0.01% |
133
| – | – |
|
400
Ventyx Biosciences
VTYX
$184M
| $29.6K | ﹤0.01% |
13,592
+5,310
| +64% | +$11.6K |
|